Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | Max |
|---|---|---|---|---|---|---|---|---|---|
| Total return | −3.8% | +6.8% | +8.3% | −17.7% | +12.8% | +38.2% | +134.1% | −6.2% | +70.5% |
| Peer average | −1.7% | +1.7% | +5.8% | +4.3% | +21.7% | +26.7% | +69.8% | +26.0% | — |
| S&P 500 · VOO | −0.3% | +3.3% | −1.6% | −2.2% | +11.9% | +12.1% | +80.1% | +73.9% | — |
$24 of every $1,000 in BBC is Xencor
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | XNCRXencor | Healthcare | 2.40% | $239.56 | 20K | $811K |
| 2 | KODKodiak Sciences | Healthcare | 2.37% | $237.28 | 7,349 | $804K |
| 3 | TRAXFirst Tracks Biotherapeutics | Healthcare | 2.12% | $211.70 | 14K | $717K |
| 4 | REPLReplimune Group | Healthcare | 1.81% | $181.26 | 28K | $614K |
| 5 | ABCLAbCellera Biologics | Healthcare | 1.69% | $168.53 | 48K | $571K |
| 6 | AMLXAmylyx Pharmaceuticals | Healthcare | 1.61% | $161.07 | 17K | $545K |
| 7 | VRDNViridian Therapeutics | Healthcare | 1.41% | $141.25 | 15K | $478K |
| 8 | SGPSpyGlass Pharma | Healthcare | 1.40% | $140.15 | 14K | $475K |
| 9 | MANEVeraDermics | Healthcare | 1.20% | $120.43 | 2,605 | $408K |
| 10 | MBXMBX Biosciences | Healthcare | 1.20% | $120.15 | 7,049 | $407K |
| 11 | LBRXLB Pharmaceuticals | Healthcare | 1.16% | $116.26 | 8,806 | $394K |
| 12 | KYMRKymera Therapeutics | Healthcare | 1.16% | $115.59 | 2,903 | $391K |
| 13 | PRMEPrime Medicine | Healthcare | 1.15% | $114.51 | 90K | $388K |
| 14 | ORKAOruka Therapeutics | Healthcare | 1.13% | $113.33 | 3,581 | $384K |
| 15 | MAZEMAZE Therapeutics | Healthcare | 1.13% | $112.85 | 10K | $382K |
of the $112B in 39 Health care ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | XNCR | Xencor | 2.40% |
| 2 | KOD | Kodiak Sciences | 2.37% |
| 3 | TRAX | First Tracks Biotherapeutics | 2.12% |
| 4 | REPL | Replimune Group | 1.81% |
| 5 | ABCL | AbCellera Biologics | 1.69% |
| 6 | AMLX | Amylyx Pharmaceuticals | 1.61% |
| 7 | VRDN | Viridian Therapeutics | 1.41% |
| 8 | SGP | SpyGlass Pharma | 1.40% |
| 9 | MANE | VeraDermics | 1.20% |
| 10 | MBX | MBX Biosciences | 1.20% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Dec 22, 2025 | Dec 29, 2025 | $0.66 |
| Dec 20, 2024 | Dec 27, 2024 | $0.24 |
| Dec 20, 2023 | Dec 29, 2023 | $0.0823 |
| Dec 20, 2017 | Dec 27, 2017 | $0.30 |
| Dec 21, 2015 | Dec 29, 2015 | $0.15 |